Why this grouping
MONDO alignment & provenance
The grouping concept corresponds to the MONDO familial isolated dilated cardiomyopathy class as that class is defined ("a rare familial cardiomyopathy characterized by the dilation of left ventricle and progressively impairing of systolic ventricular function, in the absence of abnormal loading conditions or coronary artery disease... isolated when no additional atypical cardiac or extracardiac manifestations are present"; Orphanet:154). MONDO:0700335 is preferred over the broader MONDO:0016333 (familial dilated cardiomyopathy, which carries the OMIM CMD phenotypic series OMIMPS:115200) because the isolated qualifier is exactly the boundary this grouping draws. Numbered CMD entities in MONDO without DisMech entries are curation gaps rather than evidence that the grouping concept is only a close match.
MONDO consistency: consistent All thirteen listed members were verified to be direct MONDO children of MONDO:0700335, so the grouping's membership does not diverge from MONDO's asserted hierarchy - in contrast to the Familial Hypertrophic Cardiomyopathy grouping, where syndromic phenocopies inherited from an OMIM phenotypic series had to be excluded by hand. One nuance is worth recording rather than hiding: MONDO additionally places `dilated cardiomyopathy 1A` (MONDO:0007269, LMNA) under `syndromic disease` (MONDO:0002254), reflecting the laminopathy spectrum's skeletal-muscle involvement. It is retained as a member because the DisMech entry curates the isolated cardiac phenotype, with the Emery-Dreifuss/limb-girdle allelic overlap recorded on the member rather than treated as a syndromic exclusion.
Membership criteria
- HAS PHENOTYPE
Dilated cardiomyopathy HP:0001644
Annotated with dilated cardiomyopathy, or one of its descendants.
- CONFORMS TO MODULE
module: cardiomyopathy_maladaptive_remodeling
Declares conformance to the conserved structural/contractile cardiomyopathy remodelling module.
Coverage and gaps
Exact MONDO scope: MONDO:0700335 · familial isolated dilated cardiomyopathy Completeness is counted over rows inside this exact MONDO scope that are listed in this grouping.
| Status | DisMech entry | MONDO concept | In DisMech | Has MONDO ID | In grouping MONDO | Member state | Conditions satisfied | C1.1 Annotated with dilated cardiomyopathy, or one of its descendants. HP:0001644 | C2.1 Declares conformance to the conserved structural/contractile cardiomyopathy remodelling module. |
|---|---|---|---|---|---|---|---|---|---|
| listed in scope |
Dilated Cardiomyopathy 2G
DISEASE
Differentiating mechanismLeiomodin-2 (LMOD2), which nucleates and elongates actin at the pointed end of the thin filament and thereby sets its length - a *geometric* lesion unique in the group, in which motor, calcium regulation, Z-disc scaffold and quality-control machinery are all intact but the filament is built to the wrong specification, degrading thin-thick overlap. It is also the group's most severe member and its second recessive one: biallelic loss means the neonatal heart never has functional leiomodin-2, so there is no compensated phase and presentation is at birth, frequently lethal.
module: cardiomyopathy_maladaptive_remodeling
LMOD2 hgnc:6648
|
cardiomyopathy, dilated, 2G
MONDO:0030887
|
yes | yes | yes | listed | satisfied | SATISFIED | SATISFIED |
| listed in scope |
Dilated Cardiomyopathy 1A
DISEASE
Differentiating mechanismLamin A/C (LMNA), the A-type intermediate filaments of the nuclear lamina - the group's only nuclear-envelope lesion, and the member whose distinctiveness is temporal rather than structural. What sets CMD1A apart is the order in which the myocardium fails: sinus node dysfunction, progressive atrioventricular block and atrial arrhythmia typically precede ventricular dilation by years. Malignant ventricular arrhythmia and sudden death can occur with minimal or no systolic dysfunction, so defibrillator decisions here follow gene-specific risk models rather than ejection fraction - a property it shares with RBM20 (CMD1DD) and with no other member. A skeletal myopathy with contractures occurs in part of the spectrum, reflecting allelic overlap with Emery-Dreifuss and limb-girdle muscular dystrophy 1B.
module: cardiomyopathy_maladaptive_remodeling
LMNA hgnc:6636
|
dilated cardiomyopathy 1A
MONDO:0007269
|
yes | yes | yes | listed | satisfied | SATISFIED | SATISFIED |
| listed in scope |
Dilated Cardiomyopathy 1AA
DISEASE
Differentiating mechanismAlpha-actinin-2 (ACTN2), the principal cross-linker of antiparallel actin filaments at the Z-disc, which also anchors the titin N-terminus and scaffolds Z-disc partners - a lesion of the sarcomere's anchoring apparatus rather than of the contractile stroke or its regulation. Distinguished within the group by the breadth of its allelic series and by a nosological disagreement the entry preserves: the phenotype may occur alone or with left ventricular noncompaction, and ACTN2 also causes hypertrophic (CMH23), restrictive and left-dominant arrhythmogenic cardiomyopathy plus a skeletal myopathy. ClinGen lumps that whole spectrum into a single ACTN2-related entity with Definitive validity, while MONDO keeps the phenotype-specific nodes separate; this grouping follows MONDO's split.
module: cardiomyopathy_maladaptive_remodeling
ACTN2 hgnc:164
|
dilated cardiomyopathy 1AA
MONDO:0012808
|
yes | yes | yes | listed | satisfied | SATISFIED | SATISFIED |
| listed in scope |
Dilated Cardiomyopathy 1B
DISEASE
Differentiating mechanismThe linkage-defined member: an autosomal dominant familial dilated cardiomyopathy locus mapped in 1995 to chromosome 9q13-q22 in which no causal gene has been identified in the three decades since, so MONDO defines the entity by chromosomal region rather than by gene. It carries no gene descriptor for that reason, and it is the group's representative of the substantial fraction of familial dilated cardiomyopathy that remains genetically unexplained - a reminder that the grouping's boundary is drawn on phenotype, inheritance and mechanism, not on possession of a named causal gene. It is the direct counterpart of Hypertrophic Cardiomyopathy 21 in the hypertrophic series.
module: cardiomyopathy_maladaptive_remodeling
|
dilated cardiomyopathy 1B
MONDO:0010951
|
yes | yes | yes | listed | satisfied | SATISFIED | SATISFIED |
| listed in scope |
Dilated Cardiomyopathy 1D
DISEASE
Differentiating mechanismCardiac troponin T (TNNT2), the tropomyosin-binding subunit anchoring the troponin complex to the thin filament. It is the member whose separation from its hypertrophic counterpart is experimentally measured rather than inferred: in one system the dilated alleles (DeltaK210, R141W) decreased the calcium sensitivity of force generation while the hypertrophic allele R94L increased it. Notably the two dilated alleles sit in different parts of the molecule - one inside the strong tropomyosin-binding region, one outside it - yet desensitize equally, so the direction of the calcium shift rather than variant location tracks with phenotype.
module: cardiomyopathy_maladaptive_remodeling
TNNT2 hgnc:11949
|
dilated cardiomyopathy 1D
MONDO:0011095
|
yes | yes | yes | listed | satisfied | SATISFIED | SATISFIED |
| listed in scope |
Dilated Cardiomyopathy 1DD
DISEASE
Differentiating mechanismRNA binding motif protein 20 (RBM20), a heart-enriched splicing factor - the group's only post-transcriptional lesion, acting one level above the sarcomere by mis-building its transcripts rather than by damaging its proteins. Its principal client is titin: RBM20 governs the N2B/N2BA isoform switch that sets passive myocardial stiffness, so CMD1DD and CMD1G converge on titin from opposite directions. Disease alleles cluster as a missense hotspot in the RS domain. Clinically it sits with the arrhythmogenic left ventricular cardiomyopathy genes: early malignant ventricular arrhythmia occurs disproportionate to systolic impairment, and left ventricular systolic function is an insensitive predictor of arrhythmic risk.
module: cardiomyopathy_maladaptive_remodeling
RBM20 hgnc:27424
|
dilated cardiomyopathy 1DD
MONDO:0013168
|
yes | yes | yes | listed | satisfied | SATISFIED | SATISFIED |
| listed in scope |
Dilated Cardiomyopathy 1E
DISEASE
Differentiating mechanismThe cardiac voltage-gated sodium channel Nav1.5 (SCN5A) - the group's mechanistic outlier, and the only member whose causal protein is an ion channel with no structural, regulatory or maintenance role in the myocyte. The same gene's other alleles cause the primary channelopathies (Brugada syndrome, progressive cardiac conduction disease), so this member sits at the boundary between electrical and structural heart disease. The founding allele D1275N cosegregates with a composite phenotype of dilated cardiomyopathy, atrial fibrillation, impaired automaticity and conduction delay, and the route from channel defect to ventricular dilation remains unestablished.
module: cardiomyopathy_maladaptive_remodeling
SCN5A hgnc:10593
|
dilated cardiomyopathy 1E
MONDO:0011003
|
yes | yes | yes | listed | satisfied | SATISFIED | SATISFIED |
| listed in scope |
Dilated Cardiomyopathy 1G
DISEASE
Differentiating mechanismTitin (TTN), the sarcomeric molecular ruler, elastic spring and mechanosensing scaffold, and by a wide margin the group's largest contributor - truncating variants account for roughly 25% of familial and 18% of sporadic idiopathic dilated cardiomyopathy. It is also the member with the most distinctive interpretive rule: pathogenicity is positional, concentrated in the inextensible A-band, and TTN truncating variants occur in the general population, so a truncating variant is not by itself a diagnosis. Penetrance accordingly splits by ascertainment - above 95% in clinically ascertained families over 40, substantially lower among population carriers.
module: cardiomyopathy_maladaptive_remodeling
TTN hgnc:12403
|
dilated cardiomyopathy 1G
MONDO:0011400
|
yes | yes | yes | listed | satisfied | SATISFIED | SATISFIED |
| listed in scope |
Dilated Cardiomyopathy 1HH
DISEASE
Differentiating mechanismBCL2-associated athanogene 3 (BAG3), the co-chaperone that organizes chaperone-assisted selective autophagy (CASA) at the Z-disc - the group's protein-quality-control lesion, and the member whose causal protein is not part of the contractile apparatus at all. Working with Hsc70 and HSPB8, BAG3 disposes of force-unfolded Z-disc components such as filamin so they can be replaced; a loss-of-function allele removes maintenance capacity rather than force-generating capacity, and impaired CASA leads to Z-disc disintegration. It is the dilated-series counterpart of KLHL24 (CMH29) in the hypertrophic series, where the causal lesion is likewise proteostatic rather than sarcomeric.
module: cardiomyopathy_maladaptive_remodeling
BAG3 hgnc:939
|
dilated cardiomyopathy 1HH
MONDO:0013479
|
yes | yes | yes | listed | satisfied | SATISFIED | SATISFIED |
| listed in scope |
Dilated Cardiomyopathy 1I
DISEASE
Differentiating mechanismDesmin (DES), the muscle-specific intermediate filament that links successive Z-discs to each other, to the sarcolemma, to mitochondria and to the nuclear envelope - the group's cytoskeletal-scaffold lesion, degrading lateral force transmission and mechanical registration rather than force generation. Distinguished by two allele classes acting differently (dominant missense disrupting filament assembly; recessive truncating abolishing desmin), by desmin-positive sarcoplasmic aggregates, and by being the cardiac-predominant pole of a spectrum whose skeletal-predominant pole this KB curates separately as myofibrillar myopathy.
module: cardiomyopathy_maladaptive_remodeling
DES hgnc:2770
|
dilated cardiomyopathy 1I
MONDO:0011482
|
yes | yes | yes | listed | satisfied | SATISFIED | SATISFIED |
| listed in scope |
Dilated Cardiomyopathy 1S
DISEASE
Differentiating mechanismBeta-cardiac myosin heavy chain (MYH7), the thick-filament motor - the same protein whose other alleles cause hypertrophic cardiomyopathy 1. This member exists to carry the group's cleanest allelic contrast: the dilated alleles (Ser532Pro, Phe764Leu) diminish contractile function and the ventricle dilates, where the hypertrophic alleles increase it and the ventricle thickens. The founding study states the principle directly - distinct mutations in one sarcomere protein trigger two different remodelling programmes - and affected individuals show neither antecedent hypertrophy nor hypertrophic histopathology.
module: cardiomyopathy_maladaptive_remodeling
MYH7 hgnc:7577
|
dilated cardiomyopathy 1S
MONDO:0013262
|
yes | yes | yes | listed | satisfied | SATISFIED | SATISFIED |
| listed in scope |
Dilated Cardiomyopathy 1Z
DISEASE
Differentiating mechanismCardiac troponin C (TNNC1), the calcium sensor of the thin filament. It is the member where the route from lesion to dilated phenotype is least settled, and the entry preserves that: three competing mechanistic models are curated - thin-filament calcium desensitization, phosphorylation-uncoupling derived from explanted human myocardium, and a kinetic model of halved force-activation rate - rather than a single asserted chain. TNNC1 is also pleiotropic in the same way TNNI3 is, causing hypertrophic (CMH13) and restrictive cardiomyopathy from different substitutions in one small protein.
module: cardiomyopathy_maladaptive_remodeling
TNNC1 hgnc:11943
|
dilated cardiomyopathy 1Z
MONDO:0012745
|
yes | yes | yes | listed | satisfied | SATISFIED | SATISFIED |
| listed in scope |
Dilated Cardiomyopathy 2A
DISEASE
Differentiating mechanismCardiac troponin I (TNNI3), the inhibitory subunit of the troponin complex, and the group's only recessive member: CMD2A is caused by biallelic loss-of-function genotypes, mechanistically distinct from the far commoner heterozygous TNNI3 missense disease that produces hypertrophic (CMH7) and restrictive cardiomyopathy. Its distinguishing feature is a developmentally timed onset found nowhere else in the group - the fetal and neonatal heart expresses slow skeletal troponin I instead of cTnI, so a cTnI-null heart is protected until the perinatal isoform switch withdraws that substitute, and affected children are typically well at birth before decompensating in the first months of life.
module: cardiomyopathy_maladaptive_remodeling
TNNI3 hgnc:11947
|
dilated cardiomyopathy 2A
MONDO:0012746
|
yes | yes | yes | listed | satisfied | SATISFIED | SATISFIED |
| DisMech not listed |
Dilated Cardiomyopathy 1EE
DISEASE
|
dilated cardiomyopathy 1EE
MONDO:0013198
|
yes | yes | yes | not listed | not evaluated | not evaluated | not evaluated |
| DisMech not listed |
Dilated Cardiomyopathy 1JJ
DISEASE
|
dilated cardiomyopathy 1JJ
MONDO:0014095
|
yes | yes | yes | not listed | not evaluated | not evaluated | not evaluated |
| DisMech not listed |
Dilated Cardiomyopathy 1Y
DISEASE
|
dilated cardiomyopathy 1Y
MONDO:0012744
|
yes | yes | yes | not listed | not evaluated | not evaluated | not evaluated |
| DisMech not listed |
left ventricular noncompaction 10
MONDO:0014163
|
yes | yes | yes | not listed | not evaluated | not evaluated | not evaluated | |
| DisMech not listed |
Left Ventricular Noncompaction 8
DISEASE
|
left ventricular noncompaction 8
MONDO:0014152
|
yes | yes | yes | not listed | not evaluated | not evaluated | not evaluated |
| MONDO gap | No DisMech entry |
cardiomyopathy, dilated, 2D
MONDO:0030300
|
no | yes | yes | not curated | not evaluated | not evaluated | not evaluated |
| MONDO gap | No DisMech entry |
cardiomyopathy, dilated, 2E
MONDO:0030366
|
no | yes | yes | not curated | not evaluated | not evaluated | not evaluated |
| MONDO gap | No DisMech entry |
cardiomyopathy, dilated, 2F
MONDO:0030680
|
no | yes | yes | not curated | not evaluated | not evaluated | not evaluated |
| MONDO gap | No DisMech entry |
cardiomyopathy, dilated, 2H
MONDO:0859358
|
no | yes | yes | not curated | not evaluated | not evaluated | not evaluated |
| MONDO gap | No DisMech entry |
cardiomyopathy, dilated, 2c
MONDO:0032592
|
no | yes | yes | not curated | not evaluated | not evaluated | not evaluated |
| MONDO gap | No DisMech entry |
dilated cardiomyopathy 1BB
MONDO:0013030
|
no | yes | yes | not curated | not evaluated | not evaluated | not evaluated |
| MONDO gap | No DisMech entry |
dilated cardiomyopathy 1C
MONDO:0011094
|
no | yes | yes | not curated | not evaluated | not evaluated | not evaluated |
| MONDO gap | No DisMech entry |
dilated cardiomyopathy 1CC
MONDO:0013147
|
no | yes | yes | not curated | not evaluated | not evaluated | not evaluated |
| MONDO gap | No DisMech entry |
dilated cardiomyopathy 1FF
MONDO:0013211
|
no | yes | yes | not curated | not evaluated | not evaluated | not evaluated |
| MONDO gap | No DisMech entry |
dilated cardiomyopathy 1GG
MONDO:0013339
|
no | yes | yes | not curated | not evaluated | not evaluated | not evaluated |
| MONDO gap | No DisMech entry |
dilated cardiomyopathy 1H
MONDO:0011425
|
no | yes | yes | not curated | not evaluated | not evaluated | not evaluated |
| MONDO gap | No DisMech entry |
dilated cardiomyopathy 1II
MONDO:0014073
|
no | yes | yes | not curated | not evaluated | not evaluated | not evaluated |
| MONDO gap | No DisMech entry |
dilated cardiomyopathy 1K
MONDO:0011567
|
no | yes | yes | not curated | not evaluated | not evaluated | not evaluated |
| MONDO gap | No DisMech entry |
dilated cardiomyopathy 1KK
MONDO:0014100
|
no | yes | yes | not curated | not evaluated | not evaluated | not evaluated |
| MONDO gap | No DisMech entry |
dilated cardiomyopathy 1L
MONDO:0011702
|
no | yes | yes | not curated | not evaluated | not evaluated | not evaluated |
| MONDO gap | No DisMech entry |
dilated cardiomyopathy 1M
MONDO:0011840
|
no | yes | yes | not curated | not evaluated | not evaluated | not evaluated |
| MONDO gap | No DisMech entry |
dilated cardiomyopathy 1NN
MONDO:0014396
|
no | yes | yes | not curated | not evaluated | not evaluated | not evaluated |
| MONDO gap | No DisMech entry |
dilated cardiomyopathy 1O
MONDO:0012062
|
no | yes | yes | not curated | not evaluated | not evaluated | not evaluated |
| MONDO gap | No DisMech entry |
dilated cardiomyopathy 1P
MONDO:0012362
|
no | yes | yes | not curated | not evaluated | not evaluated | not evaluated |
| MONDO gap | No DisMech entry |
dilated cardiomyopathy 1Q
MONDO:0012364
|
no | yes | yes | not curated | not evaluated | not evaluated | not evaluated |
| MONDO gap | No DisMech entry |
dilated cardiomyopathy 1R
MONDO:0013261
|
no | yes | yes | not curated | not evaluated | not evaluated | not evaluated |
| MONDO gap | No DisMech entry |
dilated cardiomyopathy 1U
MONDO:0013371
|
no | yes | yes | not curated | not evaluated | not evaluated | not evaluated |
| MONDO gap | No DisMech entry |
dilated cardiomyopathy 1V
MONDO:0013373
|
no | yes | yes | not curated | not evaluated | not evaluated | not evaluated |
| MONDO gap | No DisMech entry |
dilated cardiomyopathy 1W
MONDO:0012667
|
no | yes | yes | not curated | not evaluated | not evaluated | not evaluated |
| MONDO gap | No DisMech entry |
dilated cardiomyopathy 1X
MONDO:0012704
|
no | yes | yes | not curated | not evaluated | not evaluated | not evaluated |
| MONDO gap | No DisMech entry |
dilated cardiomyopathy 2B
MONDO:0013848
|
no | yes | yes | not curated | not evaluated | not evaluated | not evaluated |
| MONDO gap | No DisMech entry |
dilated cardiomyopathy 3B
MONDO:0010542
|
no | yes | yes | not curated | not evaluated | not evaluated | not evaluated |
Source
View YAML on GitHubRaw YAML
name: Familial Dilated Cardiomyopathy
display_name: Familial Isolated Dilated Cardiomyopathy (CMD Series)
creation_date: "2026-08-23T00:00:00Z"
description: >-
Familial dilated cardiomyopathy is the Mendelian form of dilated cardiomyopathy:
left ventricular or biventricular dilation with impaired contraction, not
explained by abnormal loading conditions or coronary artery disease, arising from
a heritable defect of the cardiomyocyte and occurring in isolation - that is,
without the additional cardiac or extracardiac manifestations that would make it
one feature of a syndrome. The group is conventionally enumerated as the numbered
CMD series. Members share one clinical endpoint - a dilated, poorly contracting,
fibrotic ventricle progressing to heart failure and arrhythmia - but differ
strikingly in which part of the cardiomyocyte fails to reach it. Unlike the
hypertrophic series, whose causal genes are overwhelmingly sarcomeric, the
familial dilated cardiomyopathies are mechanistically heterogeneous: the causal
lesion may be sarcomeric, Z-disc structural, nuclear-envelope,
protein-quality-control, or post-transcriptional. That heterogeneity, converging on one
remodelling pathway, is what this grouping records.
grouping_basis:
- SHARED_MECHANISM
- SHARED_PHENOTYPE
grouping_rationale: >-
Grouped as a curated union rather than as a further Disease entry. DisMech
already has an umbrella entry for dilated cardiomyopathy at MONDO:0005021
(`Dilated Cardiomyopathy`, covering the general mechanism plus the acquired and
secondary causes) and separate entries for the individual familial forms.
MONDO:0700335 sits between them, and a Disease entry for it would duplicate the
umbrella's pathograph while asserting nothing the members do not already assert.
A Grouping is the shape that adds information here: it records *which* curated
entries constitute the familial isolated subset, *why* the boundary falls where
it does, and *what* distinguishes each member from its siblings.
Members are kept as separate Disease entries because the perturbed component
differs in kind, not merely in identity. Four mechanistic classes are represented:
a thin-filament or sarcomeric lesion (TNNC1, TNNI3, and the titin spring in TTN);
a Z-disc structural lesion (ACTN2); a nuclear-envelope lesion (LMNA); a
protein-quality-control lesion (BAG3); and a post-transcriptional lesion (RBM20).
They differ further in allele class and dose (dominant missense in TNNC1 versus
biallelic loss of function in TNNI3; positionally restricted truncation in TTN),
and in the order in which the myocardium fails - LMNA disease characteristically
leads with conduction disease and arrhythmia years before dilation, whereas the
sarcomeric forms lead with contractile failure.
Only NECESSARY criteria are asserted; the sufficient direction is deliberately
withheld, and here the reason is concrete rather than theoretical. Both
qualifying clauses in the class definition - "familial" and "isolated" - are
precisely the parts that cannot be reduced to a machine-checkable positive
condition over the KB. A SUFFICIENT criterion built from "manifests dilated
cardiomyopathy" plus "conforms to the maladaptive remodelling module" was checked
against the KB and would sweep in three non-members: the `Dilated Cardiomyopathy`
umbrella entry (this grouping's own superclass), `DSP Cardiomyopathy` (an
arrhythmogenic desmosomal cardiomyopathy that dilates but belongs to a different
nosologic class), and `Left Ventricular Noncompaction 8` (a distinct
morphological entity). Asserting sufficiency would therefore make the criteria
contradict the grouping's own boundary.
mappings:
mondo_mappings:
- term:
id: MONDO:0700335
label: familial isolated dilated cardiomyopathy
mapping_predicate: skos:exactMatch
mapping_source: MONDO
mapping_justification: >-
The grouping concept corresponds to the MONDO familial isolated dilated
cardiomyopathy class as that class is defined ("a rare familial
cardiomyopathy characterized by the dilation of left ventricle and
progressively impairing of systolic ventricular function, in the absence of
abnormal loading conditions or coronary artery disease... isolated when no
additional atypical cardiac or extracardiac manifestations are present";
Orphanet:154). MONDO:0700335 is preferred over the broader MONDO:0016333
(familial dilated cardiomyopathy, which carries the OMIM CMD phenotypic
series OMIMPS:115200) because the isolated qualifier is exactly the boundary
this grouping draws. Numbered CMD entities in MONDO without DisMech entries
are curation gaps rather than evidence that the grouping concept is only a
close match.
consistency:
- reference: MONDO
consistent: CONSISTENT
notes: >-
All thirteen listed members were verified to be direct MONDO children of
MONDO:0700335, so the grouping's membership does not diverge from MONDO's
asserted hierarchy - in contrast to the Familial Hypertrophic Cardiomyopathy
grouping, where syndromic phenocopies inherited from an OMIM phenotypic
series had to be excluded by hand. One nuance is worth recording rather than
hiding: MONDO additionally places `dilated cardiomyopathy 1A`
(MONDO:0007269, LMNA) under `syndromic disease` (MONDO:0002254), reflecting
the laminopathy spectrum's skeletal-muscle involvement. It is retained as a
member because the DisMech entry curates the isolated cardiac phenotype,
with the Emery-Dreifuss/limb-girdle allelic overlap recorded on the member
rather than treated as a syndromic exclusion.
membership_criteria:
- description: >-
Every member manifests dilated cardiomyopathy - left ventricular or
biventricular dilation with impaired contraction that is not explained by
abnormal loading conditions or coronary artery disease - annotated as
dilated cardiomyopathy (HP:0001644). Members must additionally be Mendelian
(familial) and isolated (without the additional cardiac or extracardiac
manifestations that would make the cardiomyopathy one feature of a syndrome);
both clauses are stated here in prose rather than as structured leaves, because
neither HAS_INHERITANCE nor "absence of extracardiac features" is
machine-evaluable and an UNKNOWN leaf inside this conjunction would mask the
clause that is checkable.
criteria_semantics: NECESSARY
logic:
criterion_predicate: HAS_PHENOTYPE
phenotype_term:
preferred_term: Dilated cardiomyopathy
term:
id: HP:0001644
label: Dilated cardiomyopathy
description: >-
Annotated with dilated cardiomyopathy, or one of its descendants.
evidence:
- reference: PMID:31073128
reference_title: "Dilated cardiomyopathy."
supports: SUPPORT
evidence_source: OTHER
snippet: >-
Dilated cardiomyopathy (DCM) is a clinical diagnosis characterized by left
ventricular or biventricular dilation and impaired contraction that is not
explained by abnormal loading conditions (for example, hypertension and
valvular heart disease) or coronary artery disease.
explanation: >-
States the defining clinical criterion used by this block, including the
exclusion of loading conditions and coronary disease. Evidence source is
OTHER because this is a Nature Reviews Disease Primers review.
- reference: PMID:21353195
reference_title: "Genome-wide studies of copy number variation and exome sequencing identify rare variants in BAG3 as a cause of dilated cardiomyopathy."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Familial dilated cardiomyopathy has been shown to be caused by rare variant
mutations in more than 30 genes but only ~35% of its genetic cause has been
identified, principally by using linkage-based or candidate gene discovery
approaches.
explanation: >-
Supports the Mendelian/familial clause of this criterion and quantifies the
genetic heterogeneity that makes the group large and incompletely resolved -
the reason a locus-only member such as CMD1B belongs in it.
- description: >-
Every member's dilation is a primary, heritable disorder of the cardiomyocyte
that reaches the dilated phenotype through the conserved maladaptive
remodelling pathway - primary cardiomyocyte insult, neurohormonal activation,
ventricular remodelling, progressive contractile dysfunction, heart failure -
rather than through pressure or volume overload, ischaemia, or an infiltrative
process. In the KB this is recorded as declared conformance to the
cardiomyopathy_maladaptive_remodeling module.
criteria_semantics: NECESSARY
logic:
criterion_predicate: CONFORMS_TO_MODULE
module: cardiomyopathy_maladaptive_remodeling
description: >-
Declares conformance to the conserved structural/contractile cardiomyopathy
remodelling module.
evidence:
- reference: PMID:31073128
reference_title: "Dilated cardiomyopathy."
supports: SUPPORT
evidence_source: OTHER
snippet: >-
Mutations in several genes can cause DCM, including genes encoding structural
components of the sarcomere and desmosome.
explanation: >-
Establishes the heritable structural basis shared by the group. Evidence
source is OTHER because this is a review.
- reference: PMID:31073128
reference_title: "Dilated cardiomyopathy."
supports: SUPPORT
evidence_source: OTHER
snippet: >-
As DCM eventually leads to impaired contractility, standard approaches to
prevent or treat heart failure are the first-line treatment for patients with
DCM.
explanation: >-
Names the shared convergence on impaired contractility and heart failure that
the maladaptive remodelling arm of this criterion refers to.
members:
- member: Dilated Cardiomyopathy 1A
member_type: DISEASE
disease_term:
preferred_term: dilated cardiomyopathy 1A
term:
id: MONDO:0007269
label: dilated cardiomyopathy 1A
differentiating_mechanisms:
- description: >-
Lamin A/C (LMNA), the A-type intermediate filaments of the nuclear lamina -
the group's only nuclear-envelope lesion, and the member whose distinctiveness
is temporal rather than structural. What sets CMD1A apart is the order in
which the myocardium fails: sinus node dysfunction, progressive
atrioventricular block and atrial arrhythmia typically precede ventricular
dilation by years. Malignant ventricular arrhythmia and sudden death can occur
with minimal or no systolic dysfunction, so defibrillator decisions here follow
gene-specific risk models rather than ejection fraction - a property it shares
with RBM20 (CMD1DD) and with no other member. A skeletal myopathy with
contractures occurs in part of the spectrum, reflecting allelic overlap with
Emery-Dreifuss and limb-girdle muscular dystrophy 1B.
gene:
preferred_term: LMNA
term:
id: hgnc:6636
label: LMNA
module: cardiomyopathy_maladaptive_remodeling#Ventricular Remodeling
- member: Dilated Cardiomyopathy 1AA
member_type: DISEASE
disease_term:
preferred_term: dilated cardiomyopathy 1AA
term:
id: MONDO:0012808
label: dilated cardiomyopathy 1AA
differentiating_mechanisms:
- description: >-
Alpha-actinin-2 (ACTN2), the principal cross-linker of antiparallel actin
filaments at the Z-disc, which also anchors the titin N-terminus and scaffolds
Z-disc partners - a lesion of the sarcomere's anchoring apparatus rather than
of the contractile stroke or its regulation. Distinguished within the group by
the breadth of its allelic series and by a nosological disagreement the entry
preserves: the phenotype may occur alone or with left ventricular
noncompaction, and ACTN2 also causes hypertrophic (CMH23), restrictive and
left-dominant arrhythmogenic cardiomyopathy plus a skeletal myopathy. ClinGen
lumps that whole spectrum into a single ACTN2-related entity with Definitive
validity, while MONDO keeps the phenotype-specific nodes separate; this
grouping follows MONDO's split.
gene:
preferred_term: ACTN2
term:
id: hgnc:164
label: ACTN2
module: cardiomyopathy_maladaptive_remodeling#Ventricular Remodeling
- member: Dilated Cardiomyopathy 1B
member_type: DISEASE
disease_term:
preferred_term: dilated cardiomyopathy 1B
term:
id: MONDO:0010951
label: dilated cardiomyopathy 1B
differentiating_mechanisms:
- description: >-
The linkage-defined member: an autosomal dominant familial dilated
cardiomyopathy locus mapped in 1995 to chromosome 9q13-q22 in which no causal
gene has been identified in the three decades since, so MONDO defines the
entity by chromosomal region rather than by gene. It carries no gene descriptor
for that reason, and it is the group's representative of the substantial
fraction of familial dilated cardiomyopathy that remains genetically
unexplained - a reminder that the grouping's boundary is drawn on phenotype,
inheritance and mechanism, not on possession of a named causal gene. It is the
direct counterpart of Hypertrophic Cardiomyopathy 21 in the hypertrophic
series.
module: cardiomyopathy_maladaptive_remodeling#Ventricular Remodeling
- member: Dilated Cardiomyopathy 1D
member_type: DISEASE
disease_term:
preferred_term: dilated cardiomyopathy 1D
term:
id: MONDO:0011095
label: dilated cardiomyopathy 1D
differentiating_mechanisms:
- description: >-
Cardiac troponin T (TNNT2), the tropomyosin-binding subunit anchoring the
troponin complex to the thin filament. It is the member whose separation from
its hypertrophic counterpart is experimentally measured rather than inferred:
in one system the dilated alleles (DeltaK210, R141W) decreased the calcium
sensitivity of force generation while the hypertrophic allele R94L increased
it. Notably the two dilated alleles sit in different parts of the molecule -
one inside the strong tropomyosin-binding region, one outside it - yet
desensitize equally, so the direction of the calcium shift rather than variant
location tracks with phenotype.
gene:
preferred_term: TNNT2
term:
id: hgnc:11949
label: TNNT2
module: cardiomyopathy_maladaptive_remodeling#Ventricular Remodeling
- member: Dilated Cardiomyopathy 1DD
member_type: DISEASE
disease_term:
preferred_term: dilated cardiomyopathy 1DD
term:
id: MONDO:0013168
label: dilated cardiomyopathy 1DD
differentiating_mechanisms:
- description: >-
RNA binding motif protein 20 (RBM20), a heart-enriched splicing factor - the
group's only post-transcriptional lesion, acting one level above the sarcomere
by mis-building its transcripts rather than by damaging its proteins. Its
principal client is titin: RBM20 governs the N2B/N2BA isoform switch that sets
passive myocardial stiffness, so CMD1DD and CMD1G converge on titin from
opposite directions. Disease alleles cluster as a missense hotspot in the RS
domain. Clinically it sits with the arrhythmogenic left ventricular
cardiomyopathy genes: early malignant ventricular arrhythmia occurs
disproportionate to systolic impairment, and left ventricular systolic function
is an insensitive predictor of arrhythmic risk.
gene:
preferred_term: RBM20
term:
id: hgnc:27424
label: RBM20
module: cardiomyopathy_maladaptive_remodeling#Ventricular Remodeling
- member: Dilated Cardiomyopathy 1E
member_type: DISEASE
disease_term:
preferred_term: dilated cardiomyopathy 1E
term:
id: MONDO:0011003
label: dilated cardiomyopathy 1E
differentiating_mechanisms:
- description: >-
The cardiac voltage-gated sodium channel Nav1.5 (SCN5A) - the group's
mechanistic outlier, and the only member whose causal protein is an ion
channel with no structural, regulatory or maintenance role in the myocyte.
The same gene's other alleles cause the primary channelopathies (Brugada
syndrome, progressive cardiac conduction disease), so this member sits at the
boundary between electrical and structural heart disease. The founding allele
D1275N cosegregates with a composite phenotype of dilated cardiomyopathy,
atrial fibrillation, impaired automaticity and conduction delay, and the route
from channel defect to ventricular dilation remains unestablished.
gene:
preferred_term: SCN5A
term:
id: hgnc:10593
label: SCN5A
module: cardiomyopathy_maladaptive_remodeling#Ventricular Remodeling
- member: Dilated Cardiomyopathy 1G
member_type: DISEASE
disease_term:
preferred_term: dilated cardiomyopathy 1G
term:
id: MONDO:0011400
label: dilated cardiomyopathy 1G
differentiating_mechanisms:
- description: >-
Titin (TTN), the sarcomeric molecular ruler, elastic spring and mechanosensing
scaffold, and by a wide margin the group's largest contributor - truncating
variants account for roughly 25% of familial and 18% of sporadic idiopathic
dilated cardiomyopathy. It is also the member with the most distinctive
interpretive rule: pathogenicity is positional, concentrated in the
inextensible A-band, and TTN truncating variants occur in the general
population, so a truncating variant is not by itself a diagnosis. Penetrance
accordingly splits by ascertainment - above 95% in clinically ascertained
families over 40, substantially lower among population carriers.
gene:
preferred_term: TTN
term:
id: hgnc:12403
label: TTN
module: cardiomyopathy_maladaptive_remodeling#Ventricular Remodeling
- member: Dilated Cardiomyopathy 1HH
member_type: DISEASE
disease_term:
preferred_term: dilated cardiomyopathy 1HH
term:
id: MONDO:0013479
label: dilated cardiomyopathy 1HH
differentiating_mechanisms:
- description: >-
BCL2-associated athanogene 3 (BAG3), the co-chaperone that organizes
chaperone-assisted selective autophagy (CASA) at the Z-disc - the group's
protein-quality-control lesion, and the member whose causal protein is not
part of the contractile apparatus at all. Working with Hsc70 and HSPB8, BAG3
disposes of force-unfolded Z-disc components such as filamin so they can be
replaced; a loss-of-function allele removes maintenance capacity rather than
force-generating capacity, and impaired CASA leads to Z-disc disintegration.
It is the dilated-series counterpart of KLHL24 (CMH29) in the hypertrophic
series, where the causal lesion is likewise proteostatic rather than
sarcomeric.
gene:
preferred_term: BAG3
term:
id: hgnc:939
label: BAG3
module: cardiomyopathy_maladaptive_remodeling#Ventricular Remodeling
- member: Dilated Cardiomyopathy 1I
member_type: DISEASE
disease_term:
preferred_term: dilated cardiomyopathy 1I
term:
id: MONDO:0011482
label: dilated cardiomyopathy 1I
differentiating_mechanisms:
- description: >-
Desmin (DES), the muscle-specific intermediate filament that links successive
Z-discs to each other, to the sarcolemma, to mitochondria and to the nuclear
envelope - the group's cytoskeletal-scaffold lesion, degrading lateral force
transmission and mechanical registration rather than force generation.
Distinguished by two allele classes acting differently (dominant missense
disrupting filament assembly; recessive truncating abolishing desmin), by
desmin-positive sarcoplasmic aggregates, and by being the cardiac-predominant
pole of a spectrum whose skeletal-predominant pole this KB curates separately
as myofibrillar myopathy.
gene:
preferred_term: DES
term:
id: hgnc:2770
label: DES
module: cardiomyopathy_maladaptive_remodeling#Ventricular Remodeling
- member: Dilated Cardiomyopathy 1S
member_type: DISEASE
disease_term:
preferred_term: dilated cardiomyopathy 1S
term:
id: MONDO:0013262
label: dilated cardiomyopathy 1S
differentiating_mechanisms:
- description: >-
Beta-cardiac myosin heavy chain (MYH7), the thick-filament motor - the same
protein whose other alleles cause hypertrophic cardiomyopathy 1. This member
exists to carry the group's cleanest allelic contrast: the dilated alleles
(Ser532Pro, Phe764Leu) diminish contractile function and the ventricle
dilates, where the hypertrophic alleles increase it and the ventricle
thickens. The founding study states the principle directly - distinct
mutations in one sarcomere protein trigger two different remodelling
programmes - and affected individuals show neither antecedent hypertrophy nor
hypertrophic histopathology.
gene:
preferred_term: MYH7
term:
id: hgnc:7577
label: MYH7
module: cardiomyopathy_maladaptive_remodeling#Ventricular Remodeling
- member: Dilated Cardiomyopathy 1Z
member_type: DISEASE
disease_term:
preferred_term: dilated cardiomyopathy 1Z
term:
id: MONDO:0012745
label: dilated cardiomyopathy 1Z
differentiating_mechanisms:
- description: >-
Cardiac troponin C (TNNC1), the calcium sensor of the thin filament. It is the
member where the route from lesion to dilated phenotype is least settled, and
the entry preserves that: three competing mechanistic models are curated -
thin-filament calcium desensitization, phosphorylation-uncoupling derived from
explanted human myocardium, and a kinetic model of halved force-activation rate
- rather than a single asserted chain. TNNC1 is also pleiotropic in the same
way TNNI3 is, causing hypertrophic (CMH13) and restrictive cardiomyopathy from
different substitutions in one small protein.
gene:
preferred_term: TNNC1
term:
id: hgnc:11943
label: TNNC1
module: cardiomyopathy_maladaptive_remodeling#Ventricular Remodeling
- member: Dilated Cardiomyopathy 2A
member_type: DISEASE
disease_term:
preferred_term: dilated cardiomyopathy 2A
term:
id: MONDO:0012746
label: dilated cardiomyopathy 2A
differentiating_mechanisms:
- description: >-
Cardiac troponin I (TNNI3), the inhibitory subunit of the troponin complex,
and the group's only recessive member: CMD2A is caused by biallelic
loss-of-function genotypes, mechanistically distinct from the far commoner
heterozygous TNNI3 missense disease that produces hypertrophic (CMH7) and
restrictive cardiomyopathy. Its distinguishing feature is a developmentally
timed onset found nowhere else in the group - the fetal and neonatal heart
expresses slow skeletal troponin I instead of cTnI, so a cTnI-null heart is
protected until the perinatal isoform switch withdraws that substitute, and
affected children are typically well at birth before decompensating in the
first months of life.
gene:
preferred_term: TNNI3
term:
id: hgnc:11947
label: TNNI3
module: cardiomyopathy_maladaptive_remodeling#Ventricular Remodeling
- member: Dilated Cardiomyopathy 2G
member_type: DISEASE
disease_term:
preferred_term: cardiomyopathy, dilated, 2G
term:
id: MONDO:0030887
label: cardiomyopathy, dilated, 2G
differentiating_mechanisms:
- description: >-
Leiomodin-2 (LMOD2), which nucleates and elongates actin at the pointed end of
the thin filament and thereby sets its length - a *geometric* lesion unique in
the group, in which motor, calcium regulation, Z-disc scaffold and
quality-control machinery are all intact but the filament is built to the
wrong specification, degrading thin-thick overlap. It is also the group's most
severe member and its second recessive one: biallelic loss means the neonatal
heart never has functional leiomodin-2, so there is no compensated phase and
presentation is at birth, frequently lethal.
gene:
preferred_term: LMOD2
term:
id: hgnc:6648
label: LMOD2
module: cardiomyopathy_maladaptive_remodeling#Ventricular Remodeling
notes: >-
Scope decision. This entity was curated as a `kb/groupings/` union rather than as
a Disease entry, for the same reason as the Familial Hypertrophic Cardiomyopathy
grouping: DisMech already covers general dilated cardiomyopathy at MONDO:0005021
and the individual familial forms as separate entries, so MONDO:0700335's
curatable content is exactly the membership boundary and the per-member
differentiators.
Deliberately excluded, with reasons. (1) `Dilated Cardiomyopathy` (MONDO:0005021)
- the superclass of this grouping, not a member; a grouping points down at its
members, and the umbrella additionally covers acquired and secondary causes.
(2) `DSP Cardiomyopathy`, `PKP2 Cardiomyopathy`, `Naxos disease`, `Carvajal
Syndrome` and `Arrhythmogenic Right Ventricular Cardiomyopathy` - desmosomal
arrhythmogenic cardiomyopathies, a distinct nosologic class, even though the
left-dominant forms dilate. (3) The left ventricular noncompaction entries -
a distinct morphological entity. (4) Syndromic and neuromuscular entries in which
dilated cardiomyopathy is one feature of a multisystem disease (Barth syndrome,
Emery-Dreifuss muscular dystrophy, myofibrillar myopathy,
Cardiomyopathy-Hypotonia-Lactic Acidosis Syndrome) - excluded on the "isolated"
clause of the class definition. (5) Acquired dilated cardiomyopathies (Takotsubo,
peripartum, Chagas) - not heritable.
How the advisory evaluator reads these criteria. Both criteria blocks are
NECESSARY and both are single leaves, and every listed member satisfies both on
the annotations the entries actually carry: all eight carry HP:0001644 and all
eight declare `conforms_to` edges to cardiomyopathy_maladaptive_remodeling, which
was verified before the criteria were written rather than assumed. No SUFFICIENT
block is asserted; the three entries such a block would wrongly capture are named
in the grouping_rationale.
Mechanistic spread is the substantive content here. The thirteen members span
seven classes of cardiomyocyte lesion - sarcomeric thin-filament regulation
(TNNC1, TNNI3, TNNT2), sarcomeric motor (MYH7), sarcomeric spring and scaffold
(TTN), thin-filament length specification (LMOD2), Z-disc structural (ACTN2),
cytoskeletal intermediate filament (DES), nuclear envelope (LMNA), protein
quality control (BAG3), post-transcriptional (RBM20) and ion channel (SCN5A) -
plus one locus-only entity (CMD1B). This is the group's principal contrast with the
Familial Hypertrophic Cardiomyopathy grouping, whose members are overwhelmingly
sarcomeric, and it is why `grouping_basis` records SHARED_MECHANISM and
SHARED_PHENOTYPE but deliberately not SHARED_GENE_FAMILY.
Curation gaps. Ten of the eleven genes with ClinGen Definitive validity for
dilated cardiomyopathy are now represented as members: TTN, LMNA, MYH7, TNNT2,
TNNC1, DES, SCN5A, BAG3, RBM20 and LMOD2 (ACTN2 is a member on MONDO's split of
the ACTN2 spectrum; TNNI3 is represented by the recessive CMD2A entity).
FLNC is the one Definitive gene curated but deliberately NOT admitted as a member.
`FLNC-Related Dilated Cardiomyopathy` exists as a DisMech entry, named after the
ClinGen gene-disease pair and covering the truncating allele class. It is held out
of this grouping for two reasons. First, its phenotype is an overlapping dilated
and left-dominant *arrhythmogenic* cardiomyopathy rather than an isolated dilated
one, so it falls outside the "isolated" clause of the class definition. Second,
it carries no MONDO mapping - there is no numbered CMD class for FLNC-related
dilated cardiomyopathy, and the alternatives are each wrong in a different way
(MONDO:0016189, qualitative or quantitative defects of filamin C, is a
filaminopathy class spanning the myopathies; MONDO:0005021 is the general
umbrella) - so it cannot satisfy the verified relationship this grouping's
mapping records, in which every member is a direct MONDO child of MONDO:0700335.
Admitting it would weaken a claim the grouping currently makes honestly. The
non-truncating FLNC allele class is curated separately again, as
`Hypertrophic Cardiomyopathy 26` and `Myofibrillar Myopathy`.
Numerous further numbered CMD entities exist in MONDO with limited or disputed
gene-disease validity; those are lower-value.